EGFR and non-small cell lung carcinoma: Taken together result of the above in-silico analysis, it can be inferred that 18α-GA may exert its therapeutic effects on NSCLC by regulating ErbB signaling and PI3K/AKT signaling pathway, which is widely involved in tumor proliferation, apoptosis, and metastasis regulation.